Melanoma and more report to different codes.
Not a lot will change once you start reporting malignant skin neoplasms with ICD-10, but we have the low-down on a few key differences to keep your diagnosis coding on track for skin biopsy and excision cases.
Recall: CMS has finalized the ICD-10 implementation date for Oct. 1, 2014, delaying the action one year from the original deadline.
Stay the Course for Excludes/Includes
Both C44 in ICD-10 and 173 in ICD-9 (Other and unspecified malignant neoplasm of skin) include malignant neoplasm of sebaceous glands. The two code families also share the same condition exclusions, as follows:
Expect Greater ICD-10 Site Detail
You'll find a direct crosswalk between other and unspecified neoplasm of skin codes for ICD-9 and ICD-10 at the fourth-digit level, as follows:
You'll also find fifth-digit agreement between ICD-9 and ICD-10 for these codes, as follows:
Embrace the difference: The one significant change from ICD-9 to ICD-10 for these codes is the addition of a sixth digit to further zero in on the lesion site.
For bilateral sites (eyelid, C44.1_; ear, C44.2_; upper limb, C44.6_; lower limb, C44.7_) you'll have the following three choices for sixth digits:
The sixth digit definitions are a little different form some sites, as follows:
1 -- unspecified
2 -- nose
9 -- other parts of face
1 -- anal/perianal
2 -- breast
9 -- other part of trunk.
There are no sixth digit options for C44.0_, C44.4_, C44.8_ and C44.9_.